vitiligo
Conditions
Interventions
test group:lattice Laser + compound betamethasone injection / triamcinolone acetonide injection + NB-UVB
control group:Betamethasone cream + NB-UVB
Sponsors
The First Hospital of China Medical University
Eligibility
Sex/Gender
All
Age
14 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) age 14-65 years old, inpatient or outpatient, male or female; (2) meet the diagnostic criteria of clinically diagnosed primary acral or sporadic in patients with acromegaly leukoplakia, or skin lesions symmetrically distributed in the sacral iliac carina parts; (3) subjects volunteered to participate, be required to sign an informed consent form; (4) whether or not the body with or without white spots, hands back or carina parts (such as sacral iliac sudden Long) needs with white markings and basic symmetrical on both sides at least there is a greater than 1cm; (5) All cases must for the progress of patients; (6) regardless of previous treatment.
Exclusion criteria
Exclusion criteria: (1) pregnant and lactating women; (2) serious heart, liver, renal insufficiency; (3) pre-cancerous skin lesions; (4) systemic lupus erythematosus (SLE), dermatomyositis ultraviolet treatment contraindications; (5) with immunosuppressive therapy; (6) hand infection or past treatment caused skin damage is not significant improvement or treatment; (7) secondary vitiligo (secondary to discoid lupus erythematosus, chronic eczema, vitiligo); (8) can not adhere to treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lesions chang; | — |
Countries
China
Contacts
Public ContactXing-hua Gao
Outcome results
None listed